Why the study?
Does antiarrhythmia therapy retard sudden death in Doberman pinschers with dilated cardiomyopathy and ventricular tachycardia?
Does antiarrhythmia therapy retard sudden death in Doberman pinschers with dilated cardiomyopathy and ventricular tachycardia?
Answers are grounded in this paper and cite their sources.
Antiarrhythmic therapy may delay sudden death in Doberman pinschers with dilated cardiomyopathy and ventricular arrhythmias.
Overtly healthy Doberman pinschers, having moderate to severe myocardial failure secondary to dilated cardiomyopathy, which experienced ventricular tachycardia, syncope or collapse, and sudden death were studied to determine the effect of antiarrhythmic medication on their clinical outcome. Antiarrhythmia drug therapy may have retarded sudden death in 13 treated dogs compared to the six dogs not administered antiarrhythmia drugs.
No takes yet. Share an insight, caveat, or question.
Calvert et al. (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: